DEVELOPMENT OF DEGRADABLE POLYESTERURETHANES FOR MEDICAL APPLICATIONS- IN-VITRO AND IN-VIVO EVALUATIONS

Citation
B. Saad et al., DEVELOPMENT OF DEGRADABLE POLYESTERURETHANES FOR MEDICAL APPLICATIONS- IN-VITRO AND IN-VIVO EVALUATIONS, Journal of biomedical materials research, 36(1), 1997, pp. 65-74
Citations number
20
Categorie Soggetti
Engineering, Biomedical","Materials Science, Biomaterials
ISSN journal
00219304
Volume
36
Issue
1
Year of publication
1997
Pages
65 - 74
Database
ISI
SICI code
0021-9304(1997)36:1<65:DODPFM>2.0.ZU;2-C
Abstract
To evaluate the biocompatibility of a newly developed degradable class of polyesterurethanes and their possible use as biomaterials, we inve stigated the cell and tissue interactions with these polymers using a small number of chemical base entities. The polymers were prepared by chain extension with diisocyanates of PHB/HV-diol and either PCL-diol or Diorez, another aliphatic polyester-diol. Regardless of the chemica l composition of the four tested polyesterurethanes used as substrates , no morphological difference was observed either in the macrophages ( macrophage cell Line J774) or in the fibroblasts (fibroblast cell line 3T3) cultured on these polymers. In contrast, however, cell adhesion and growth of macrophages and fibroblasts were affected by the polymer properties. Compared to macrophages cultured on tissue culture polyst yrene (TCPS), cells cultured on the test polymers exhibited levels of cell adhesion that varied from 65-100% of TCPS, and the doubling time was 25-43% higher on the polymers than on TCPS. Likewise, fibroblasts adhered to the polymers at lower rates (50-85% of TCPS) and grew at hi gher doubling times (125-140% of TCPS). Furthermore, cells cultured on the test polymers preserved their phenotypes: fibroblasts produced hi gh amounts (up to 280% of control cells) of collagens Type I and Type IV and fibronectin; and macrophages produced nitric oxide (NO) and tum or necrosis factor alpha (TNF-alpha) in the same concentrations as con trol cells and responded to lipopolysaccharide treatment by the elevat ion of the production of NO and TNF-alpha, indicating that the cell-to -polymer interactions allow fibroblasts and macrophages to maintain th eir phenotypes. In vivo investigations showed that all four test polym ers exhibit favorable tissue compatibility. The formed capsule was 60- 250 mu m thick. Ln addition, the polymers are degradable. After one ye ar's subcutaneous implantation in rats, the molecular weight of the te st polymers were reduced to about 50%, depending on the composition. T aken collectively, the present data demonstrate that the newly develop ed polyesterurethanes are cell and tissue compatible and biodegradable . (C) 1997 John Wiley & Sons, Inc.